These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 30524448)

  • 21. Increased expression of CD69 on T cells as an early immune marker for human cytomegalovirus reactivation in chronic lymphocytic leukemia patients.
    Petersen CC; Nederby L; Roug AS; Skovbo A; Peterslund NA; Hokland P; Nielsen B; Hokland M
    Viral Immunol; 2011 Apr; 24(2):165-9. PubMed ID: 21449727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4
    Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T
    Front Immunol; 2018; 9():1129. PubMed ID: 29887865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4⁺ T cells.
    Mason GM; Jackson S; Okecha G; Poole E; Sissons JG; Sinclair J; Wills MR
    PLoS Pathog; 2013; 9(10):e1003635. PubMed ID: 24130479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody.
    Meng W; Tang A; Ye X; Gui X; Li L; Fan X; Schultz RD; Freed DC; Ha S; Wang D; Zhang N; Fu TM; An Z
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late Development of FcεRγ
    Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
    Front Immunol; 2018; 9():1050. PubMed ID: 29868012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An M2 Rather than a T
    Lee DH; Ghiasi H
    J Virol; 2018 May; 92(10):. PubMed ID: 29491152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention.
    Groves IJ; Jackson SE; Poole EL; Nachshon A; Rozman B; Schwartz M; Prinjha RK; Tough DF; Sinclair JH; Wills MR
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follicular helper T-cells and virus-specific antibody response in primary and reactivated human cytomegalovirus infections of the immunocompetent and immunocompromised transplant patients.
    Bruno F; Fornara C; Zelini P; Furione M; Carrara E; Scaramuzzi L; Cane I; Mele F; Sallusto F; Lilleri D; Gerna G
    J Gen Virol; 2016 Aug; 97(8):1928-1941. PubMed ID: 27113912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation.
    Borchers S; Luther S; Lips U; Hahn N; Kontsendorn J; Stadler M; Buchholz S; Diedrich H; Eder M; Koehl U; Ganser A; Mischak-Weissinger E
    Transpl Infect Dis; 2011 Jun; 13(3):222-36. PubMed ID: 21585633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CMV-encoded G protein-coupled receptors M33 and US28 play pleiotropic roles in immune evasion and alter host T cell responses.
    White TM; Bonavita CM; Stanfield BA; Farrell HE; Davis-Poynter NJ; Cardin RD
    Front Immunol; 2022; 13():1047299. PubMed ID: 36569845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-Responsive Genes Are Targeted during the Establishment of Human Cytomegalovirus Latency.
    Elder EG; Krishna BA; Williamson J; Lim EY; Poole E; Sedikides GX; Wills M; O'Connor CM; Lehner PJ; Sinclair J
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation, maintenance and tissue distribution of T cell responses to human cytomegalovirus in lytic and latent infection.
    Jackson SE; Sedikides GX; Okecha G; Wills MR
    Med Microbiol Immunol; 2019 Aug; 208(3-4):375-389. PubMed ID: 30895366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
    Rölle A; Olweus J
    APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune control of cytomegalovirus reactivation in stem cell transplantation.
    Degli-Esposti MA; Hill GR
    Blood; 2022 Mar; 139(9):1277-1288. PubMed ID: 34166512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function.
    Mason GM; Poole E; Sissons JG; Wills MR; Sinclair JH
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14538-43. PubMed ID: 22826250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human cytomegalovirus reactivation from latency: validation of a "switch" model in vitro.
    Arcangeletti MC; Vasile Simone R; Rodighiero I; De Conto F; Medici MC; Maccari C; Chezzi C; Calderaro A
    Virol J; 2016 Oct; 13(1):179. PubMed ID: 27770817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation.
    Ludwig B; Kraus FB; Kipp M; Preiser W; Schwerdtfeger R; Doerr HW; Buxbaum S
    J Clin Virol; 2006 Feb; 35(2):160-6. PubMed ID: 16112610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
    Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel murine model of differentiation-mediated cytomegalovirus reactivation from latently infected bone marrow haematopoietic cells.
    Liu XF; Swaminathan S; Yan S; Engelmann F; Abbott DA; VanOsdol LA; Heald-Sargent T; Qiu L; Chen Q; Iovane A; Zhang Z; Abecassis MM
    J Gen Virol; 2019 Dec; 100(12):1680-1694. PubMed ID: 31647403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-2 from Adaptive T Cells Enhances Natural Killer Cell Activity against Human Cytomegalovirus-Infected Macrophages.
    Wu Z; Frascaroli G; Bayer C; Schmal T; Mertens T
    J Virol; 2015 Jun; 89(12):6435-41. PubMed ID: 25855747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.